These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 7750288

  • 1. Influence of high doses of vitamin C on the bioavailability and the serum protein binding of levonorgestrel in women using a combination oral contraceptive.
    Kuhnz W, Louton T, Hümpel M, Back DJ, Zamah NM.
    Contraception; 1995 Feb; 51(2):111-6. PubMed ID: 7750288
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W, al-Yacoub G, Fuhrmeister A.
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [Abstract] [Full Text] [Related]

  • 4. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
    Abdalla KA, Shabaan MM, Stanczyk FZ.
    Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
    Kuhnz W, al-Yacoub G.
    Horm Res; 1991 Feb; 35(5):178-81. PubMed ID: 1802819
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Baumann A, Staks T, Dibbelt L, Knuppen R, Jütting G.
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W, Klinger G, Jäger R, Kasch R, Brandstädt A.
    Exp Clin Endocrinol; 1992 Oct; 99(1):12-7. PubMed ID: 1628691
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 11. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 12. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 13. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
    Cullberg G, Samsioe G, Andersen RF, Bredesgaard P, Andersen NB, Ernerot H, Fanøe E, Fylling P, Haack-Sørensen PE, Klottrup P, Pedersen JH, Sandager T.
    Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028
    [Abstract] [Full Text] [Related]

  • 14. Sex hormone binding globulin and free levonorgestrel index in the first week after insertion of Norplant implants.
    Alvarez F, Brache V, Tejada AS, Cochon L, Faundes A.
    Contraception; 1998 Oct; 58(4):211-4. PubMed ID: 9866001
    [Abstract] [Full Text] [Related]

  • 15. Lansoprazole does not affect the bioavailability of oral contraceptives.
    Fuchs W, Sennewald R, Klotz U.
    Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
    Bergink EW, Holma P, Pyörälä T.
    Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
    Song S, Chen JK, He ML, Fotherby K.
    Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
    [Abstract] [Full Text] [Related]

  • 19. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P.
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [Abstract] [Full Text] [Related]

  • 20. Absence of an effect of high vitamin C dosage on the systemic availability of ethinyl estradiol in women using a combination oral contraceptive.
    Zamah NM, Hümpel M, Kuhnz W, Louton T, Rafferty J, Back DJ.
    Contraception; 1993 Oct; 48(4):377-91. PubMed ID: 8222665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.